Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
6.66
-0.40 (-5.67%)
At close: Oct 28, 2025, 4:00 PM EDT
6.66
0.00 (0.02%)
After-hours: Oct 28, 2025, 7:58 PM EDT
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $1.73 billion as of October 28, 2025. Its market cap has decreased by -62.60% in one year.
Market Cap
1.73B
Enterprise Value
10.03B
1-Year Change
-62.60%
Ranking
Category
Stock Price
$6.66
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $1.73B, a decrease of -79.43%. That is a compound annual growth rate of -29.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 1.84B | -52.24% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
| May 14, 2021 | 8.42B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.90B |
| Johnson & Johnson | 457.53B |
| AbbVie | 402.83B |
| UnitedHealth Group | 331.46B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.35B |